91
Participants
Start Date
July 31, 2006
Primary Completion Date
September 30, 2009
bortezomib
1.3 mg/m2 on Days 1, 4, 8 \& 11 every 3 weeks (1 cycle = 21 days) for up to six cycles
pegylated liposomal doxorubicin
30 mg/m2 on Day 1 every 3 weeks (1 cycle = 21 days) for up to six cycles
Division of Gynecologic Oncology, Università Catholica Sacre Cuore, Campbasso
Istituto Europeo di Oncologia (IEO), Milan
Istituto Nazionale dei Tumori, Milan
Dept. Procreational Medicine, Università di Pisa, Pisa
Kantonsspital St. Gallen, Sankt Gallen
Gynecologic Oncology Unit, Ospedale Sant' Anna
Istituto Oncologico della Svizzera Italiana, Bellinzona
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY